D rug addiction is a mental illness that is viewed as a transition from recreational use to compulsive drug-seeking and -taking 1-3 . This behavioral transition is proposed to be controlled by 'drug-evoked plasticity' 1-4 . However, exactly how synaptic plasticity controls the adaptive changes in drug-seeking behavior remains unclear. The dorsomedial striatum (DMS), a brain region crucially involved in drug and alcohol addiction, receives glutamatergic inputs from several brain areas 2,5-7 . In these neural circuits, the medial prefrontal cortex (mPFC) afferent into the DMS is essential for the control of goal-directed behaviors 2,5-7 , and this connection is linked to drug or alcohol addiction 2,5,8 . For example, exposure to drugs of abuse or alcohol potentiates AMPA receptor (AMPAR)-and NMDA receptor (NMDAR)-mediated glutamatergic transmission in the DMS 8-11 , while pharmacological inhibition of striatal glutamatergic transmission transiently suppresses operant alcohol self-administration and cocaine relapse 9, 10, 12, 13 . Although these studies indicate that drugs and alcohol evoke corticostriatal plasticity, which may, in turn, contribute to drug-seeking and -taking behaviors, there has been no direct demonstration that synaptic plasticity drives addictive behaviors.
D rug addiction is a mental illness that is viewed as a transition from recreational use to compulsive drug-seeking and -taking [1] [2] [3] . This behavioral transition is proposed to be controlled by 'drug-evoked plasticity' [1] [2] [3] [4] . However, exactly how synaptic plasticity controls the adaptive changes in drug-seeking behavior remains unclear. The dorsomedial striatum (DMS), a brain region crucially involved in drug and alcohol addiction, receives glutamatergic inputs from several brain areas 2, [5] [6] [7] . In these neural circuits, the medial prefrontal cortex (mPFC) afferent into the DMS is essential for the control of goal-directed behaviors 2, [5] [6] [7] , and this connection is linked to drug or alcohol addiction 2, 5, 8 . For example, exposure to drugs of abuse or alcohol potentiates AMPA receptor (AMPAR)-and NMDA receptor (NMDAR)-mediated glutamatergic transmission in the DMS [8] [9] [10] [11] , while pharmacological inhibition of striatal glutamatergic transmission transiently suppresses operant alcohol self-administration and cocaine relapse 9, 10, 12, 13 . Although these studies indicate that drugs and alcohol evoke corticostriatal plasticity, which may, in turn, contribute to drug-seeking and -taking behaviors, there has been no direct demonstration that synaptic plasticity drives addictive behaviors.
The DMS contains two types of medium spiny neurons (MSNs): D1-MSNs express dopamine D1 receptors (D1Rs) and D2-MSNs contain dopamine D2 receptors (D2Rs) 14 . Both neuronal types receive mPFC inputs 12 . While synaptic plasticity, including longterm potentiation (LTP) and depression (LTD), was observed in both D1-and D2-MSNs 15 , drug-or alcohol-induced plasticity was found predominantly in striatal D1-MSNs 12, 16, 17 . Mimicking alcohol-evoked plasticity by inducing LTP, or reversing this plasticity by inducing LTD, will provide a new understanding of how this plasticity controls alcohol-seeking behavior. LTP and LTD induction at specific neuronal circuits requires simultaneous control of both pre-and postsynaptic neurons, which can be achieved using a recently developed dual-channel optogenetic technique 18, 19 .
In this study, we paired optogenetic postsynaptic depolarization (oPSD) with presynaptic glutamatergic stimulation; this greatly enhanced NMDAR-mediated transmission and induced a reliable NMDAR-dependent LTP, as well as an endocannabinoid (eCB)-dependent LTD. Notably, in vivo optogenetic delivery of the LTP protocol to the corticostriatal synapses within the DMS produced a long-lasting increase in operant self-administration of alcohol. Conversely, delivery of the LTD protocol led to a longlasting decrease in this behavior. Furthermore, we discovered that the in vivo LTP and LTD protocols preferentially induced plasticity in D1-MSNs and that selective induction of LTP or LTD in this neuronal type produced the corresponding changes in alcohol-seeking behavior. These findings demonstrate a causal link between DMS corticostriatal synaptic plasticity and alcoholseeking behavior and indicate that the reversal of drug-evoked synaptic plasticity may provide a novel therapeutic strategy for the treatment of alcohol use disorder.
Results

oPSD facilitates induction of NMDAR-dependent LTP and eCB-LTD in the DMS.
In dorsostriatal slices, LTD is the easiest form of synaptic plasticity to observe, while LTP is more difficult to detect 6, 20 . A D2R antagonist was thus included in the external recording solution in order to prevent LTD 15 and favor the induction of LTP. Field excitatory postsynaptic potentials and population spikes were evoked by electrical stimulation within the DMS (Fig. 1a ), but these were not potentiated by electrical high-frequency stimulation (eHFS; Fig. 1b and Supplementary Fig. 1a ). This observation is consistent with previous reports 6, 21 . Previous studies also suggested that sufficient postsynaptic depolarization was necessary for reliable LTP induction 20 . Therefore, we examined whether postsynaptic depolarization by somatic current injection (iPSD) facilitated LTP induction. Using whole-cell recording, we discovered that paired eHFS and iPSD produced little LTP ( Supplementary Fig. 1b ). Addiction is proposed to arise from alterations in synaptic strength via mechanisms of long-term potentiation (LTP) and depression (LTD). However, the causality between these synaptic processes and addictive behaviors is difficult to demonstrate. Here we report that LTP and LTD induction altered operant alcohol self-administration, a motivated drug-seeking behavior. We first induced LTP by pairing presynaptic glutamatergic stimulation with optogenetic postsynaptic depolarization in the dorsomedial striatum, a brain region known to control goal-directed behavior. Blockade of this LTP by NMDA-receptor inhibition unmasked an endocannabinoid-dependent LTD. In vivo application of the LTP-inducing protocol caused a long-lasting increase in alcoholseeking behavior, while the LTD protocol decreased this behavior. We further identified that optogenetic LTP and LTD induction at cortical inputs onto striatal dopamine D1 receptor-expressing neurons controlled these behavioral changes. Our results demonstrate a causal link between synaptic plasticity and alcohol-seeking behavior and suggest that modulation of this plasticity may inspire a therapeutic strategy for addiction. This is consistent with the notion that current injection-elicited action potentials do not back-propagate to the distal dendrites of striatal neurons 20 ; insufficient depolarization of this region means that no LTP is generated. In contrast, optogenetics can be used to depolarize any process of postsynaptic neurons, with no limitation of their distance to the soma and in a noninvasive manner 22 . We observed that oPSD induced a higher distal dendritic calcium transient than iPSD ( Supplementary Fig. 2 ), suggesting that oPSD produced more effective depolarization of this region.
Bidirectional and long-lasting control of alcoholseeking behavior by corticostriatal LTP and LTD
Next, we assessed whether oPSD facilitates LTP induction. An adeno-associated virus (AAV) expressing a channelrhodopsin, C1V1 23 , was infused into the DMS, resulting in C1V1 expression in the soma and distal dendrites ( Fig. 1c ). We found that pairing eHFS with oPSD of DMS neurons induced a robust and reliable LTP, whereas oPSD alone did not ( Fig. 1d ). Furthermore, paired presynaptic stimulation and oPSD enhanced synaptic NMDAR activity and consequently Ca 2+ influx through this channel ( Supplementary  Fig. 3 ). LTP was blocked by bath application of an NMDAR antagonist, APV (Fig. 1e ). In addition, it has been reported that dorsostriatal LTP induction also depends on D1R activation 6, 15 . We found that optogenetic LTP was inhibited by a D1R antagonist, SCH 23390, and was facilitated by D1R activation ( Supplementary Fig. 4 ). Collectively, these results suggest that paired presynaptic stimulation and oPSD produced effective distal dendrite depolarization and induced robust NMDAR-dependent LTP that was strongly regulated by D1R signaling.
Unexpectedly, after blockade of optogenetic LTP by APV, LTD was observed ( Fig. 1e ). This LTD was completely abolished by bath application of an eCB CB1 receptor (CB1R) antagonist, AM251 ( Fig. 1f ). This was consistent with previous reports indicating that LTD in the dorsal striatum was mediated by the CB1R 24, 25 . Since this eCB LTD only emerged after LTP was blocked, we reasoned that LTP and LTD were induced simultaneously and that LTD was masked by LTP. To assess this possibility, we bath-applied AM251 throughout the recording period; this produced a significantly greater magnitude of LTP, as compared with that recorded in the absence of AM251 ( Fig. 1g ). Collectively, these results suggest that both NMDAR-dependent LTP and eCB LTD were induced simultaneously and that the LTP masked the LTD. oPSD facilitates corticostriatal LTP in the DMS. Corticostriatal plasticity is critical for drug-seeking behaviors 2,5-7 . We therefore examined whether oPSD facilitated LTP induction at specific corticostriatal afferents in the DMS. We expressed two channelrhodopsins simultaneously to selectively stimulate cortical inputs and oPSD of DMS neurons: Chronos 18 was expressed in the mPFC, and Chrimson 18 was expressed in the DMS ( Fig. 2a,b ). Chronosexpressing mPFC neurons and their projections to the DMS were able to follow high-frequency (up to 50 Hz) light stimulation ( Supplementary Fig. 5 ). We thus used light stimulation of 50 Hz for 2 s (oHFS), paired with oPSD of DMS neurons, to induce LTP. While oHFS of corticostriatal fibers or oPSD alone caused little potentiation ( Fig. 2c, d) , robust LTP was observed following paired oHFS and oPSD (Fig. 2c ). This corticostriatal LTP was abolished by APV or MK801, as expected ( Fig. 2e and Supplementary Fig. 6a ). Unexpectedly, no LTD was observed after LTP was blocked ( Fig. 2e and Supplementary Fig. 6b ); this contrasted with the results produced by pairing eHFS and oPSD ( Fig. 1e ). However, 
Fig. 1 | oPsD facilitated induction of NMDaR-dependent LTP and eCB LTD in DMs slices. a, Schematic
showing the bipolar stimulating electrodes (sti. elect.) used to evoke field excitatory postsynaptic potentials and population spikes (fEPSP/PS) and the objective lens for optogenetic depolarization. b, Presynaptic eHFS did not potentiate fEPSP/PS (98.59 ± 2.39% of baseline (BL), t 7 = 0.59, P = 0.57; n = 8 slices, 6 rats). Inset: sample fEPSP/PS traces at times 1 and 2; the dashed line denotes the similar fEPSP/PS level at these two timepoints. Sulpiride (sul; 20 µ M) was bath-applied to prevent LTD and favor LTP induction in this and following recordings, as indicated. c, Representative fluorescent images showing C1V1-eYFP expression in the DMS (left) and in the full-length dendrites of a DMS neuron (right). The section was counterstained with NeuroTrace (red). D, dorsal; M, medial. d, Pairing of presynaptic eHFS and oPSD (1 s), but not oPSD alone, induced robust LTP (eHFS + oPSD: 118.32 ± 2.96% of BL, t 9 = -6.18, P = 0.00016; n = 10 slices, 6 rats; oPSD: 101.59 ± 2.26% of BL, t 6 = -0.70, P = 0.51; n = 7 slices, 3 rats). Inset: sample fEPSP/PS traces at times 1 and 2; the dashed line represents the fEPSP/PS level at time 1 for comparison to the level at time 2. Scale bars: 3 ms, 0.4 mV. e, Optogenetic induction of LTP was abolished by APV (50 µ M), leading to LTD (86.75 ± 3.06% of BL, t 6 = 4.33, P = 0.0049; n = 7 slices, 6 rats). The gray line is the control LTP from d for reference. f, LTD was completely abolished by the CB1R antagonist AM251 (3 µ M; 101.32 ± 4.71% of BL, t 8 = -0.28, P = 0.79, n = 9 slices, 5 rats). g, AM251 facilitated LTP induction (130.73 ± 2.89% of BL, t 5 = -10.62, P = 0.00013; compared with the control (gray) LTP: t 14 = -2.79, *P = 0.015; n = 6 slices, 3 rats, unpaired t test). Horizontal dashed lines in e-g denote 100% of BL. Two-sided paired t tests for b and d-g, unless otherwise stated. Data are presented as mean ± s.e.m.
whole-cell recording detected a robust LTD in specific D1-MSNs ( Supplementary Fig. 6c ). This was consistent with a recent report showing that selective optogenetic stimulation of cortical inputs induced LTD only in D1-MSNs 26 . Collectively, these data suggest that paired oHFS and oPSD induce corticostriatal LTP and LTD. LTP stimulation has been demonstrated to induce expression of immediate early genes, contributing to drug addiction 27, 28 . We analyzed DMS slices and found that paired oHFS and oPSD, but not oHFS or oPSD alone, significantly increased mRNA levels of Npas4 (neuronal PAS domain protein 4), which encodes the Npas4 protein ( Fig. 2f ). This immediate early gene is associated with synaptic plasticity and positive valence experience 29, 30 .
In vivo optogenetic induction of corticostriatal LTP in the DMS produces a long-lasting increase in operant alcohol self-administration in rats.
Our ex vivo findings revealed that paired oHFS and oPSD elicited LTP in the DMS. We thus asked whether in vivo delivery of this LTP-inducing protocol (oHFS + oPSD) would alter alcohol-seeking behavior. To test this possibility, rats were trained to self-administer alcohol in operant chambers. Chronos and Chrimson were expressed as described above, and optical fibers were implanted into the DMS (Fig. 3a ). We found that in vivo delivery of this optogenetic protocol produced significant increases in active lever presses, alcohol deliveries and alcohol intake at 30 min, 2 d and 4 d after the light stimulation ( Fig. 3b and Supplementary Fig. 7a ). This increased alcohol intake resulted in elevated blood alcohol concentrations ( Supplementary Fig. 7b ,c). In contrast, oHFS or oPSD alone did not alter alcohol-seeking behavior ( Supplementary Fig. 7d,e ). Together, these data suggest that in vivo delivery of this LTP-inducing protocol is sufficient to cause long-lasting enhancement of alcohol-seeking behavior. However, systemic administration of NMDAR or D1R antagonists (MK801 or SCH 23390, respectively) blocked this effect of the LTP-inducing protocol on alcohol-seeking behavior ( Supplementary Fig. 7f ,g). Note that administration of SCH 23390 alone did not affect this behavior ( Supplementary Fig. 7h ). These results suggest that both NMDARs and D1Rs are required for the enhancement of alcoholseeking behavior by in vivo LTP induction.
Next, we asked whether the LTP-inducing protocol specifically enhanced alcohol-seeking behavior. Another cohort of rats was trained to self-administer sucrose before receiving the same LTP-inducing protocol as the alcohol group. We found that the LTP protocol did not alter the active lever presses, sucrose deliveries or sucrose intake ( Fig. 3c and Supplementary Fig. 7i ). We then asked why the same LTP-inducing protocol specifically promoted alcohol-seeking but not sucrose-seeking in rats. On day 2 post-LTP induction, both AMPAR-mediated excitatory postsynaptic currents (EPSCs) and the AMPAR/NMDAR ratio were increased in the alcohol group ( Fig. 3d,e ), but not in the sucrose group ( Fig. 3f,g) . Notably, before in vivo LTP induction, operant alcohol or sucrose self-administration had increased the AMPAR/ NMDAR ratio, as compared with the water group without operant training ( Supplementary Fig. 8a ). The increase was slightly lower in the alcohol-treated rats than in the sucrose controls, but the difference was not statistically significant (Q = 2.86, P = 0.051, Student-Newman-Keuls test). These data suggest that while operant training produced plasticity in alcohol and sucrose groups, in vivo delivery of the LTP-inducing protocol caused further longlasting synaptic potentiation selectively in the alcohol group. This difference may reflect the distinct effects of alcohol and sucrose on NMDAR activity 6,31-33 . To investigate this, we measured NMDAR activity in the DMS of rats that self-administered alcohol or .69% of BL, t 6 = -4.07, P = 0.0066; n = 7 slices, 4 rats). oHFS alone did not alter fEPSP/PS (99.60 ± 3.12% of BL, t 7 = 0.13, P = 0.90; n = 8 slices, 5 rats). d, oPSD alone did not induce LTP (104.55 ± 3.15% of BL, t 6 = -1.44, P = 0.20; n = 7 slices, 3 rats). e, Dual-channel optogenetic induction of LTP was blocked by APV (98.06 ± 3.27% of BL; t 8 = 0.59, P = 0.57; n = 9 slices, 5 rats). f, Npas4 mRNA levels were significantly increased following paired oHFS + oPSD, but not after oHFS or oPSD only (F 3,30 = 3.86, P = 0.019; *P < 0.05; n = 10, 9, 5, and 10 rats for the control, oHFS, oPSD, and oHFS + oPSD groups, respectively). Two-sided paired t tests for c-e; one-way ANOVA followed by Student-Newman-Keuls test for f. Data are presented as mean ± s.e.m.
sucrose. We found that the amplitude of NMDAR-mediated EPSCs was significantly higher in the alcohol group than in the sucrose group ( Supplementary Fig. 8b ,c; P = 0.0049). Furthermore, LTP was induced in DMS slices from the alcohol-treated rats, but not in those from the sucrose-drinking animals ( Supplementary Fig. 8d ), suggesting that alcohol-mediated facilitation of NMDAR activity 34, 35 promotes subsequent ex vivo and in vivo induction of LTP. In addition, the rectification index of AMPAR EPSCs was significantly enhanced following in vivo LTP induction (Supplementary Fig. 9 ; P = 0.0018), suggesting that this plasticity is mediated by an increase 26 , P = 0.012) and alcohol (EtOH) intake (right; F 5,49 = 10.91, P < 0.0001). *P < 0.05, **P < 0.01, ***P < 0.001 vs. BL; n = 14 rats. c, In vivo LTP induction did not alter active lever presses for sucrose (F 4,18 = 1.10, P = 0.39; n = 6 rats). d, In vivo LTP induction caused potentiation of AMPAR EPSCs on day 2 in alcohol-administered rats. Left and middle: sample traces of AMPAR EPSCs. Right: input-output curves for AMPAR EPSCs with (EtOH LTP) and without (EtOH) in vivo LTP induction (F 1, 107 = 15.62, P = 0.0005; n = 16 neurons, 5 rats (EtOH) and 13 neurons, 3 rats (EtOH LTP)). e, Representative traces and averaged data showing a significant increase in the AMPAR/NMDAR ratio by LTP induction (t 28 = -2.88, P = 0.0075; n = 13 neurons, 5 rats (EtOH) and 17 neurons, 3 rats (EtOH LTP)). f, In vivo LTP induction did not change AMPAR EPSCs from the sucrose-administered (suc) rats (F 1,99 = 1.30, P = 0.27; n = 11 neurons, 4 rats (suc) and 16 neurons, 5 rats (suc LTP)). g, AMPAR/NMDAR ratio did not change in the sucrose group after in vivo LTP induction (t 23 = 0.73, P = 0.47; n = 11 neurons, 5 rats (suc) and 14 neurons, 5 rats (suc LTP)). The dashed lines in b and c represent baseline (BL) levels for comparison to the same type of measurements at indicated timepoints post-LTP. The horizontal dashed lines in e and g denote the same level of normalized NMDAR EPSCs of two groups (top), the baseline of EPSC traces (middle), and the AMPAR EPSC levels in the EtOH (e) and sucrose (g) groups for comparison to their levels after LTP induction (bottom). Scale bars: 10 ms, 100 pA for d-g. One-way repeated-measures ANOVA for b and c; two-way repeated-measures ANOVA for d and f; two-sided unpaired t test for e and g. Data are presented as mean ± s.e.m.
in the activity of calcium-permeable AMPARs. Collectively, these results suggest that induction of corticostriatal LTP in the DMS produces a long-lasting and specific increase in operant alcohol self-administration in rats.
In vivo optogenetic delivery of an LTD-inducing protocol in the DMS produces a long-lasting decrease in alcohol-seeking behavior in rats.
Having observed the link between LTP and alcoholseeking behavior, we reasoned that reversal of alcohol-induced potentiation of corticostriatal inputs by LTD should reduce alcoholseeking behavior. To induce LTD in vivo, we systemically administered a cocktail of MK801 and a D2R antagonist, raclopride, 30 min before delivering oHFS and oPSD ( Fig. 4a ). We used these two categories of antagonists because they were employed in the ex vivo LTD experiments described above ( Fig. 1e and Supplementary  Fig. 6c ). Thirty minutes after oHFS and oPSD delivery, significant reductions in active lever presses, alcohol deliveries and alcohol intake were observed; these reductions were maintained for at least 7 d ( Fig. 4b and Supplementary Fig. 10a ). Note that neither the cocktail (MK801 + raclopride) plus oHFS ( Supplementary  Fig. 10b-d ) nor the cocktail alone ( Supplementary Fig. 10e-g) affected alcohol-seeking behavior. Together with our finding that oHFS + oPSD + MK801 induced no changes in alcohol consumption ( Supplementary Fig. 7g ), these data suggest that the in vivo LTD-inducing protocol (oHFS + oPSD + MK801 + raclopride) produces a long-lasting reduction of alcohol-seeking behavior and that this induction requires D2R blockade.
Since the LTD induction is eCB-dependent ( Fig. 1e ), we examined whether blockade of CB1Rs attenuated the effect of the LTDinducing protocol on alcohol-seeking behavior. We found that systemic administration of additional AM251 completely abolished the LTD-induced reduction of active lever presses, alcohol deliveries and alcohol intake ( Fig. 4c and Supplementary Fig. 10h -i). In contrast, AM251 itself did not alter alcohol-seeking behavior ( Supplementary Fig. 10j -l). Lastly, our ex vivo results further ascertained that the paired-pulse ratio was significantly increased ( Fig. 4d ) and that the frequency of spontaneous miniature EPSCs was decreased ( Fig. 4e ) 2 d after delivery of the LTD protocol, confirming a presynaptically expressed striatal eCB LTD. These data indicate that delivery of the in vivo LTD-inducing protocol at the corticostriatal synapses within the DMS produced a long-lasting suppression of alcohol-seeking behavior. Bottom: cumulative distributions of interevent intervals and amplitudes of mEPSCs. Inset: reduced frequency (left), but not amplitude (right), of mEPSCs after in vivo LTD induction (t 28 = 2.97, **P = 0.006 for frequency; t 28 = 1.11, P = 0.28 for amplitude; n = 13 neurons, 3 rats (control) and 17 neurons, 3 rats (LTD)). Horizontal dashed lines in b and c denote baseline (BL) levels for comparison to the same type of measurement at indicated timepoints post light-stimulation. One-way repeated-measures ANOVA for b and c; two-sided unpaired t tests for d and e. Data are presented as mean ± s.e.m. 
In vivo deliveries of LTP and LTD protocols cause plasticity preferentially in DMS D1-MSNs.
The DMS contains D1-and D2-MSNs, which have been reported to exert opposite effects on drug-and alcohol-seeking behaviors 16, 36 . We thus explored how LTP or LTD induction altered glutamatergic transmission in these two neuronal types. First, to examine ex vivo LTP induction in D1-and D2-MSNs, we infused AAV-DIO-ChR2-mCherry into the DMS of Drd1aand Drd2-Cre transgenic mice, to enable selective depolarization of D1-or D2-MSNs. Paired eHFS and oPSD induced significant LTP, which did not differ between D1-and D2-MSNs (Fig. 5a,b ). This prompted us to explore how synaptic transmission changed in these two neuronal populations following in vivo LTP induction. To achieve this, we infused Chronos into the mPFC and Chrimson into the DMS of adult rats, as described above (Fig. 3a) . D1-MSNs were labeled by retrograde beads infused into the substantia nigra pars reticulata (SNr; Fig. 5c ), whereas D2-MSNs were labeled by infusion of AAV-D2SP-eYFP ( Fig. 5c ). Two days after in vivo delivery of the LTP-inducing protocol, the AMPAR EPSC amplitude and the AMPAR/NMDAR ratio were increased in D1-MSNs, but not in D2-MSNs (Fig. 5d,e ), as compared with slices from control rats that were not exposed to light stimulation. This cell-type-specific LTP induction is likely attributable to the higher GluN2B/NMDA ratio in D1-MSNs than in D2-MSNs (Fig. 5f) , as alcohol-mediated enhancement of GluN2B promotes LTP induction 9, 37 . Collectively, these data indicate that the in vivo LTP protocol potentiated synaptic transmission selectively in D1-MSNs.
We next investigated whether LTD was also preferentially induced in D1-MSNs ex vivo and in vivo. To induce oPSD selectively in rat D1-MSNs, we infused a retrograde AAV encoding Cre (AAV5-Cre) into the SNr and a Cre-inducible AAV expressing Chrimson (AAV-Flex-Chrimson-tdTomato) 18 into the DMS. We found that in DMS slices from alcohol-naive rats, a protocol (eHFS + oPSD + MK801 + raclopride) that was similar to that used to successfully induce LTD (Fig. 1e ), caused robust LTD in D1-MSNs; this LTD was abolished by AM251 ( Fig. 6a,b ). To induce oPSD specifically in D2-MSNs, we infused AAV-D2SP-ChR2 38 into the DMS of alcohol-naive rats. We found that the same protocol of eHFS + oPSD + MK801 + raclopride did not produce any LTD in the D2-MSNs (Fig. 6a,c) , which was consistent with previous reports 21, 39 . Lastly, to ascertain whether in vivo LTD induction caused glutamatergic depression in D1-MSNs, we measured corticostriatal EPSCs in DMS slices prepared 2 d after in vivo delivery of the LTDinducing protocol. We found that the LTD protocol reduced the release probability, as indicated by the increased paired-pulse ratio, and reduced the mEPSC frequency in D1-MSNs but not D2-MSNs, as compared to neurons from control animals without LTD induction ( Fig. 6d-g) . These results indicate that in vivo LTD induction leads to long-lasting depression of corticostriatal inputs selectively onto DMS D1-MSNs. Taken together, our results suggest that in vivo delivery of optogenetic LTP and LTD protocols preferentially induced plasticity in DMS D1-MSNs.
Selective LTP and LTD induction in DMS D1-MSNs produces long-lasting changes in alcohol-seeking behavior. Finally, we examined whether in vivo induction of corticostriatal LTP or LTD directly
in DMS D1-MSNs altered alcohol-seeking behavior. For oHFS, we infused AAV-Chronos-GFP into the mPFC; for oPSD of D1-MSNs, we infused the retrograde AAV5-Cre into the SNr and AAV-Flex-Chrimson into the DMS (Fig. 7a ). These infusions led to Chronos expression at the mPFC inputs and selective Chrimson expression in DMS D1-MSNs (Fig. 7b ). In vivo LTP induction produced significant increases in active lever presses, alcohol deliveries and alcohol intake at 30 min; this effect persisted for at least 2 d ( Fig. 7c and Supplementary Fig. 11a ). However, D1-MSN oPSD alone did not alter alcohol-seeking behavior ( Fig. 7d and Supplementary Fig. 11b,c) . These data suggest that in vivo corticostriatal LTP in DMS D1-MSNs caused a long-lasting potentiation of alcohol-seeking behavior.
In contrast, we found that delivery of the in vivo LTD-inducing protocol to the mPFC input onto D1-MSNs caused sustained decreases in active lever presses, alcohol deliveries and alcohol intake at 30 min and 2 d after the light stimulation ( Fig. 7e and Supplementary Fig. 11d ). This behavioral effect was abolished by systemic administration of AM251 ( Fig. 7f and Supplementary Fig. 11e,f) , which confirmed that eCB signaling regulated this inhibition of alcohol-seeking behavior.
These data demonstrate that eCB LTD in D1-MSNs is required for the long-lasting decrease in alcohol-seeking behavior.
Discussion
In this study, we provide evidence to suggest that alcohol intake induces glutamatergic plasticity, which can be further potentiated by in vivo LTP induction, and that this causes long-lasting enhancement of alcohol-seeking behavior (Fig. 8a) . In contrast, in vivo LTD induction suppresses this plasticity and produces a long-lasting reduction of this behavior. We report that pairing high-frequency stimulation of corticostriatal afferents with oPSD of DMS neurons induces a robust NMDAR-dependent LTP, which masks an eCB LTD (Fig. 8b) . Furthermore, we discovered that LTP and LTD in D1-MSNs contributed to the alteration of alcoholseeking behavior (Fig. 8b,c) . These results provide a direct causal link between long-term synaptic plasticity within a given neural circuit (mPFC→ DMS D1-MSNs) and alcohol-seeking behavior.
Our findings also demonstrate that induction of D1-MSN LTD might be a potential therapeutic strategy for alcohol use disorder.
oPSD facilitates LTP and LTD induction in the dorsal striatum.
It has long been known that dorsostriatal LTP induction is difficult, possibly due to insufficient depolarization of striatal neurons 20, 40 . In this study, oPSD was used to strongly depolarize the distal dendrites of these neurons, thus enhancing NMDAR channel opening and calcium influx, which is required for LTP induction 20, 40 (Fig. 8b) .
Notably, blockade of LTP by NMDAR antagonists led to LTD; this is consistent with a study showing that LTP blockade by memantine shifted LTP to LTD 41 . However, APV or MK801 was found to shift the plasticity in the current research, but not in the study by Mancini et al. 41 . This discrepancy may reflect the fact that eCB LTD was induced mainly by oPSD in the presence of a D2R antagonist in the current study and by D2R activation in the previous research.
In addition, we report that dopamine D1R signaling plays a critical modulatory role in optogenetic LTP. The observations that blockade of LTP unmasks eCB LTD and that blockade of eCB LTD enhances the LTP magnitude suggest that paired high-frequency stimulation and oPSD simultaneously induce NMDAR-dependent LTP and eCB LTD. The current oPSD also facilitated LTP in specific corticostriatal input when we used dual-channel optogenetics. Precise control of both pre-and postsynaptic activity allowed us to reliably induce LTP for the first time. LTP induction is known to activate the expression of immediate early genes such as Npas4, which has recently been identified as an important factor in brain plasticity 30 . Expression of the Npas4 gene requires Ca 2+ influx and is associated with drug addiction 29 . Indeed, the mRNA level of Npas4 was increased only after paired oHFS and oPSD, suggesting that oPSD predominantly facilitates LTP at corticostriatal synapses.
Optogenetic LTP induction promotes and LTD induction suppresses alcohol-seeking behavior.
The corticostriatal circuit is believed to control goal-directed behaviors, including drug-seeking behavior 2,5-7 . In vivo optogenetic induction of corticostriatal LTP enhances alcohol-seeking behavior, suggesting a link between this plasticity and the behavior. The selective effects of LTP on operant self-administration of alcohol versus sucrose may reflect the distinct activities of these two chemicals on the rats. Operant training with alcohol, but not with sucrose, enhanced NMDAR activity and facilitated subsequent in vivo and ex vivo induction of LTP. This finding is consistent with previous reports indicating that ex vivo or in vivo alcohol exposure causes long-term facilitation of NMDAR activity 6, 10, 31, 32 , which is required for LTP induction in the dorsal striatum 6 and for operant alcohol self-administration 10 . Operant alcohol self-administration induced a smaller, but not significant ( Supplementary Fig. 8a , P = 0.051), increase in the AMPAR/ NMDAR ratio than did operant sucrose training. This ratio difference might be attributable to the higher NMDAR activity in alcohol-treated rats than in sucrose controls.
How drug (for example, cocaine)-evoked plasticity affects subsequent LTP induction is likely to depend on the degree of saturation of the plasticity. Our study reveals that operant alcohol self-administration using the fixed ratio 3 schedule induced glutamatergic plasticity (increased AMPAR/NMDAR ratio). This plasticity was not saturated because the AMPAR/NMDAR ratio was further potentiated by in vivo LTP induction, and LTP was induced in slices from alcohol-drinking animals. It is known that 1-2 d of withdrawal from cocaine exposure induces silent synapses that contain NMDARs but not AMPARs 13, [42] [43] [44] ; these can mature over time (for example, at 45 d) 13, 44, 45 and potentially contribute to subsequent LTP occlusion 46, 47 . These studies suggest that short-term withdrawal from drug exposure induces unsaturated plasticity. Since we induced LTP 24 h after the last alcohol exposure, it is not surprising that no occlusion was observed; this is consistent with previous reports 9, 37 .
Pharmacological inhibition of alcohol-evoked glutamatergic strengthening in the DMS attenuates alcohol consumption 9 . However, this inhibition is transient and disappears as the inhibitory compounds are metabolized. Furthermore, structural plasticity, such as an increased density of mushroom spines, has been observed following alcohol consumption 48 . In this study, in vivo eCB LTD induction elicited a long-lasting decrease in alcohol-seeking behavior, indicating that this plasticity mediates more sustained behavior changes 49 .
LTP and LTD in D1-MSNs affect alcohol-seeking behavior.
While the present study and others 15, 20 report that LTP can be induced in both D1-and D2-MSNs in slices from alcohol-naive animals, in vivo delivery of our LTP-inducing protocol selectively caused longlasting potentiation of corticostriatal transmission in D1-MSNs of alcohol-drinking rats. This selectivity may be attributed to the fact that alcohol consumption potentiates NMDAR activity in D1-but not D2-MSNs 16 . The current study further identified that alcohol consumption specifically potentiated GluN2B-containing NMDAR activity at the mPFC input onto D1-MSNs. Alcohol-mediated potentiation of GluN2B NMDARs was reported to facilitate LTP induction 9, 37 . Our in vivo LTD-inducing protocol also caused LTD in D1-but not D2-MSNs, because we included a D2R antagonist, which blocks LTD induction in D2-MSNs 15, 21 (Fig. 8c,d) . Our findings are in agreement with a recent report showing that eCB LTD was induced at corticostriatal inputs to D1-but not D2-MSNs 26 . Given that D1-MSNs positively control alcohol consumption 16 , it is not surprising that induction of D1-MSN LTP produced longlasting enhancement of operant alcohol self-administration, while LTD induction in this neuronal type reduced the same behavior. The induction of LTP and LTD by inducing oPSD selectively in D1-MSNs confirmed that synaptic plasticity in this neuronal type was sufficient to control alcohol-seeking behavior in a bidirectional manner. Therefore, blockade of striatal LTP induction and promotion of eCB LTD in D1-MSNs may inspire a therapeutic strategy to cause a long-lasting reduction of alcohol-seeking behavior. Although optogenetic intervention cannot be immediately translated to human use, deep brain stimulation is a treatment approved by the US Food and Drug Administration that has the potential to cause LTP 46 and probably LTD. Thus, we believe that the combined use of deep brain stimulation and antagonists of the NMDAR (for example, memantine) and D2R may provide novel clinical treatments for alcohol use disorder.
In summary, we have demonstrated that optogenetic induction of bidirectional long-term synaptic plasticity at corticostriatal afferents within the DMS produced long-lasting increases or decreases in alcohol-seeking behavior. Notably, we show that the plasticity of DMS D1-MSNs controls alcohol-seeking behavior. Our research establishes a causal link between corticostriatal synaptic potentiation and alcohol-seeking behavior and provides an evidence base for therapeutic strategies to reduce excessive alcohol consumption.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41593-018-0081-9.
Stereotaxic virus infusion.
The stereotaxic viral infusion was performed as described previously 8 . Depending on experimental design, viruses or beads were infused into the mPFC (AP: + 3.2 and + 2.6 mm, ML: ± 0.65 mm, DV: -4.0 mm from bregma), the DMS (AP1: + 1.2 mm, ML1: ± 1.9 mm, DV1: -4.7 mm; AP2: + 0.36 mm, ML2: ± 2.3 mm, DV2: -4.7 mm) and the SNr (AP1: -4.92 mm, ML1: ± 2.3 mm, DV1: -8.3 mm; AP2: -5.5 mm, ML2: ± 2.0 mm, DV2: -8.6 mm) for rats. For mice, the viruses were infused into the DMS (AP1: + 1.18 mm, ML1: ± 1.3 mm, DV1: -2.9 mm; AP2: + 0.38 mm, ML2: ± 1.55 mm, DV2: -2.9 mm from bregma). We infused 0.5-1 µ L of virus bilaterally at a rate of 0.08 µ L/min. At the end of the infusion, the injectors remained at the site for 10 min to allow for virus diffusion. Animals infused for electrophysiology were maintained in their home cages for 6-8 weeks before recordings. For animals infused with viruses for behavioral experiments, we started training them to self-administer alcohol or sucrose 1 week after surgery.
Slice preparation. The procedure has been described previously 8, 50, 51 . Briefly, coronal sections of the striatum (250 µ m in thickness) were cut in an ice-cold solution containing the following (in mM): 40 NaCl, 143.5 sucrose, 4 KCl, 1.25 NaH 2 PO 4 , 26 NaHCO 3 , 0.5 CaCl 2 , 7 MgCl 2 , 10 glucose, 1 sodium ascorbate and 3 sodium pyruvate, saturated with 95% O 2 and 5% CO 2 . Slices were then incubated in a 1:1 mixture of cutting solution and external solution at 32 °C for 45 min. The external solution was composed of the following (in mM): 125 NaCl, 4.5 KCl, 2 CaCl 2 , 1 MgCl 2 , 1.25 NaH 2 PO 4 , 25 NaHCO 3 , 15 sucrose and 15 glucose, saturated with 95% O 2 and 5% CO 2 . Slices were maintained in external solution at room temperature until use.
Field potential recording. For LTP experiments, extracellular field recordings were conducted as previously described 8 . Specifically, the recording used a patch pipette filled with 1 M NaCl and was placed within the DMS. DMS slices were visualized under an epifluorescent microscope (Examiner A1, Zeiss, Germany). Bipolar stimulating electrodes were positioned 100-150 µ m away from the recording electrode. Field excitatory postsynaptic potentials/population spikes (fEPSP/PS) 52 Whole-cell recording. In Supplementary Figs. 1, 2 Supplementary Fig. 3d,e ), 0.3 Na 3 GTP, 4 MgATP, 5 QX-314.Cl, 7 phosphocreatine, 0.05 Alexa Fluor 594 ( Supplementary Fig. 3a-e ) and 0.1 spermine ( Supplementary Fig. 9 ). The pH was adjusted to 7.3 with CsOH. Neurons were clamped at -70 mV.
For measuring NMDAR EPSPs in distal dendrites, Alexa Fluor 594 was infused through patch pipettes into the recorded neurons to label their dendrites. Under the guidance of fluorescence, the stimulating electrodes were positioned close to the Alexa Fluor-labeled dendrites and were 100-150 µ m away from the soma. AMPA receptor (AMPAR)-mediated EPSPs were recorded in 1.0 mM extracellular Mg 2+ . NBQX (10 µ M) was then bath applied to block AMPAR EPSPs. Next, simultaneous presynaptic electrical stimulation and oPSD of striatal neurons induced a response that was mediated by a C1V1-induced depolarization (V C1V1 ) plus an NMDAR response (EPSP NMDA ). Lastly, the EPSP NMDA component was blocked by bath application of APV (50 µ M), and V C1V1 was isolated. The optogenetically mediated EPSP NMDA was calculated by digital subtraction of V C1V1 from V C1V1 + EPSP NMDA . The input-output relationships for AMPAR-mediated excitatory postsynaptic currents (EPSCs) were measured at five different stimulating laser powers. For measurement of the AMPAR/NMDAR ratio, the peak currents of AMPAR-mediated EPSCs were measured at a holding potential of -70 mV and the NMDAR-mediated EPSCs were estimated as the EPSCs at + 40 mV, 30 ms after the peak AMPAR EPSCs, when the contribution of the AMPAR component was minimal. The AMPA/NMDA ratio was calculated by dividing the NMDAR EPSC by AMPAR EPSC. To measure the GluN2B/NMDA ratio, NMDAR EPSCs were recorded in the absence and presence of Ro 25-6981, and GluN2B EPSCs were calculated by subtraction of these two responses. For measuring mEPSCs, we added TTX (1 µ M) to the external solution to suppress action potential-driven release. The paired-pulse ratio (PPR) was calculated by dividing the second light-evoked EPSC by the first with 100-ms intervals between the two. To measure above synaptic transmission in specific D1-and D2-MSNs (Figs. 5 and 6), we first patched bead-positive (D1-MSNs) or eYFP-positive neurons (D2-MSNs) within a DMS area containing strong green mPFC fibers (expressing Chronos-GFP) and red Chrimson-positive neurons. We then sequentially delivered 405-nm light to stimulate the mPFC inputs and 590-nm light to induce Chrimson-mediated oPSD. The synaptic inputs and oPSD were distinguished using 2-and 100-ms light stimulation, since the prolonged light stimulation increased the duration of oPSD but not of synaptic transmission 53 . Only those neurons that received mPFC inputs and exhibited oPSD were selected for further experiments. At the end of the recording, NBQX was applied to confirm synaptic transmission induced by 405-nm light stimulation. To measure AMPAR rectification, AMPAR EPSCs were recorded at three holding potentials: -70, 0 and + 40 mV, in the presence of APV (50 μ M). Rectification index of the AMPAR EPSC was calculated by plotting the EPSC magnitude at these potentials and using the slope of the lines connecting the data between -70 and 0 mV and between 0 and 40 mV to calculate the ratio.
Calcium image. AAV-C1V1 23 and AAV-GCaMP6s 54 were infused into the DMS. Whole-cell recordings were made in C1V1-expressing neurons. GCaMP6s measures the calcium signal that is induced by current injection (iPSD) or optogenetic depolarization (oPSD; Supplementary Fig. 2 ). In Supplementary  Fig. 3f ,g, fluorescent Ca 2+ signals were elicited by eHFS or eHFS + oPSD without whole-cell recording. The distal dendrite (~120 µ m from the soma) was chosen for analysis. Ca 2+ signals were acquired and analyzed with the Zen program (Zeiss) and Origin software (Origin Lab Corporation, MA) and calculated as previously described 55 . The fluorescence signals were quantified by measuring the mean pixel intensities of the circular regions of interest (ROI). Fluorescence intensity is expressed as Δ F/F values vs. time, where F is the baseline fluorescence and Δ F is the baseline-subtracted fluorescence.
Operant self-administration of alcohol. After 1 week recovery from viral infusions, Long-Evans rats were trained to self-administer a 20% alcohol solution in operant self-administration chambers as described 56 . Each chamber contains two levers; an active lever, in which presses result in a delivery of 0.1 mL of the alcohol solution, and an inactive lever, in which presses are recorded, but no programmed events occur. After 48 h of exposure to 20% alcohol in the home cage, and one overnight session in the chamber in which pressing the active lever delivers 0.1 mL of water in a fixed ratio 1 (FR1), operant sessions were conducted 5 d per week for 2 weeks in a FR1 schedule with an active lever press resulting in the delivery of 20% alcohol with sessions shortened from 3 h to 30 min. Following the first 2 weeks, operant sessions were run 3 d per week for 1 week, and the schedule requirement was increased to FR3. After 1 week of FR3 training, rats underwent surgery for optical fiber implantation. FR3 training was resumed 1 week after the surgery. Once a stable baseline of active lever presses was achieved, animals underwent in vivo LTP and LTD induction. Following the induction, some rats were continuously monitored with their operant behavior for 7-9 d, while other rats were killed for analysis 2 d after induction for electrophysiology recordings. To test drugs' effect without LTP/LTD induction, we systematically administered the drugs 30 min before the operant behavior test. Simultaneously, we also measured inactive lever presses before and after treatment ( Supplementary Fig. 12 ).
Operant self-administration of sucrose. After a 1-week recovery from viral infusions, Long-Evans rats were trained to self-administer a 2% sucrose solution in operant chambers using the same procedure as the alcohol group described above. Optical fiber implantation was also conducted in an identical manner to the alcohol group.
Optical fiber implantation. One week following operant training with the FR3 schedule, animals were anesthetized with isoflurane and mounted in a stereotaxic frame. An incision was made, and bilateral optical fiber implants (300-nm core fiber secured to a 2.5-mm ceramic ferrule with 5 mm of fiber extending past the end of the ferrule) were lowered into the DMS (AP: + 0.36 mm; ML: ± 2.3 mm; DV: -4.6 mm from bregma). Implants were secured to the skull with metal screws and dental cement (Henry Schein) and covered with denture acrylic (Lang Dental). The incision was closed around the head cap and the skin vet-bonded to the head cap. Rats were monitored for 1 week or until they resumed normal activity.
In vivo LTP and LTD induction and operant testing.
Once a stable baseline of active lever presses was attained after optical fiber implantation, an LTP/ LTD-inducing protocol was delivered 30 min before operant testing sessions in a neutral Plexiglass chamber, with no visual cues. LTP induction consisting of paired oHFS + oPSD using the following protocol: 100 pulses at 50 Hz of 473-nm light (2 ms) with or without constant 590-nm light for 2 s, repeated four times with 20-s intervals. The protocol was repeated three times with 5-min intervals. LTD induction employed the following protocol: animals were injected with a cocktail of MK801 (0.1 mg/kg) and raclopride (0.01 mg/kg) 15 min before delivery of oHFS and oPSD. The complete LTP/LTD-inducing procedure was performed once, and 30 min later animals were allowed to press levers for alcohol in a 30-min session. Operant sessions were repeated every 48 or 72 h until active lever presses returned to their levels before the induction.
Measurement of blood alcohol concentration (BAC).
To measure blood alcohol concentration, we used the same procedure as in Fig. 3b to train two groups of rats. One week before LTP induction, we collected blood samples from the one side of the lateral saphenous vein 57 in both groups to measure baseline BAC. Thirty minutes after LTP induction, we collected blood samples from the other side of the lateral saphenous in one group of rats. Two days after the LTP induction, we collected blood samples from the other group of rats. BAC was measured using gas chromatography as previously described 58 .
RNA extraction and quantitative PCR (qPCR) analysis. The rats were infused with AAV-Chronos-GFP in the mPFC and AAV-Chrimson-tdTomato in the DMS. Coronal striatal sections (250 µ m) were prepared as described in the "Slice preparation" section above. A slice was placed in a recording chamber and perfused with the external solution at a flow rate of 3 mL/min. Optical stimuli were delivered through the objective lens to fluorescent DMS areas, which contained both GFP-expressing mPFC axons and tdTomato-expressing neurons using one of the following stimulation protocols: oHFS, oPSD or oHFS + oPSD. All protocols were repeated three times with 5-min intervals, which is the same as the in vivo LTP-inducing protocol. Thirty minutes after completing the optogenetic stimulation, DMS tissues from experimental and control groups were collected on ice. RNA isolation, reverse transcription and qRT-PCR analyses were performed as described previously 59 . The mRNA level of Npas4 was normalized against the Gapdh mRNA level in the same sample and presented as fold changes over baseline using the Δ Δ CT method. The following primers were used: Npas4, forward: 5′ -GAACCTCAAGGAACTGCTGC-3′ , reverse: 5′ -GTGCCTCCAGCAAAGAAGAC-3′ ; Gapdh, forward: 5′ -TGCCACTCAGAAGACTGTGG-3′ , reverse: 5′ -TTCAGCTCTGGGATGACCTT-3′ . For each experimental condition, two slices per rat were treated, and the averaged mRNA values were used.
Histology. Rats with viral and beads infusion were perfused intracardially with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS). The brains were taken out and put into 4% PFA/PBS solution for postfixation overnight at 4 °C, followed by dehydration in 30% sucrose solution and cryostat frozen sectioning. The brains were cut into 50-μ m coronal sections. A confocal laser-scanning microscope (Fluorview-1200, Olympus) was used to image these sections with a 470-nm laser to excite eYFP and GFP and with a 593-nm laser to excite Alexa Fluor 594 and tdTomato. All images were processed using Imaris 8.3.1 (Bitplane, Zurich, Switzerland).
Data acquisition and statistics.
In electrophysiology experiments, we used 184 rats and 10 D1-and D2-Cre mice, with 10 rats excluded prior to data collection due to virus expression in the incorrect place or expression that was too weak. In behavioral tests, we used 156 rats, of which 28 were excluded due to lack of alcohol responding in the operant setting (≤ 10 active lever presses/session), 6 were removed from data analysis due to death during surgery and 21 were removed from the last experiments due to head cap loss. In the imaging experiments, we used 11 rats.
All data are expressed as mean ± s.e.m. Each experiment was replicated in 3-7 animals. Data collection was randomized. Data were obtained and analyzed by experimenters who did not know the types of treatments of the animals, except in Figs. 3d-g, 4d ,e, 5d,e and 6d-g. No data points were excluded unless specified, and the only exclusion standard was the health condition of the animal. Data from the repeated experiments for the same substudy were pooled together for statistics. The sample size for each experiment was determined to be either at least 3 animals or 10 neurons. If in vivo changes were successfully induced in animals in Figs. 3d-g, 4d,e, 5d,e and 6d-g, we measured responses ex vivo in enough neurons to evaluate the effect of light stimulation. The sample size is presented as 'n = x, y' , where x indicates the number of slices or neurons, and y indicates the number of animals.
In electrophysiological experiments, 1-4 recordings were performed using slices from a single animal, except in Figs. 3d,e and 4d,e. Slice or neuron-based statistics were performed and reported for electrophysiology and animal-based statistics for behavioral data. Normal distribution was assumed and tested. Variance was estimated for most major results, and no significant difference was found between control and manipulation groups. Statistical significance was assessed in electrophysiological studies using unpaired or paired t tests or using two-way RM ANOVA followed by Student-Newman-Keuls (SNK) method. Behavioral studies were analyzed using the paired t test and one-way RM ANOVA followed by the SNK method. Two-tailed tests were performed for all studies. Statistical significance was set at P < 0.05.
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Experimental design 1. Sample size
Describe how sample size was determined.
No statistical methods were used to predetermine sample sizes. Animal numbers were determined based on previous or preliminary results
Data exclusions
Describe any data exclusions.
We indicate that animals with virus mis-injections, head cap loss, or lack of alcohol responding in the operant setting were excluded from analysis.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
All experiments were done in triplicate and reliably reproduced.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
All animals were randomly allocated into experimental and control groups and counterbalanced across groups.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
For the measurement and analysis of mRNA levels, experimenters were blind to experimental conditions. For electrophysiological experiments, data were analyzed blindly. For collecting post-treatment behavioral data, the experimenters were blinded to the treatments. Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated The statistical test(s) used and whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
Test values indicating whether an effect is present
Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
